QP
OCUL icon

Quilter Plc’s Ocular Therapeutix OCUL Stock Holding History

Quilter Plc’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-97,915
Closed -$979K – 267
2021
Q3 		$979K Hold
97,915
– – 0.03% 127
2021
Q2 		$1.39M Hold
97,915
– – 0.04% 113
2021
Q1 		$1.61M Buy
97,915
+175
+0.2% +$3.37K 0.05% 125
2020
Q4 		$2.02M Sell
97,740
-200
-0.2% -$2.97K 0.07% 90
2020
Q3 		$745K Sell
97,940
-4,288
-4% -$35.6K 0.03% 124
2020
Q2 		$852K Hold
102,228
– – 0.04% 114
2020
Q1 		$506K Sell
102,228
-4,873
-5% -$24.1K 0.03% 129
2019
Q4 		$423K Buy
+107,101
New +$372K 0.02% 155

Other funds holding OCUL

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Quilter Plc's OCUL Position: Q4 2021 in Review

Quilter Plc sold out of Ocular Therapeutix (OCUL) in Q4 2021, closing a stake of 97,915 shares — an estimated $979K sold.

Quilter Plc first reported a position in OCUL in Q4 2019 and held it in 8 quarters. The position peaked at $2.02M in Q4 2020. 140 funds tracked by Wall St. Rank hold OCUL as of Q4 2021.

  • Quilter Plc reported no remaining Ocular Therapeutix position as of Q4 2021 after selling out during the quarter.
  • Quilter Plc sold 97,915 Ocular Therapeutix shares in Q4 2021, an estimated $979K.
  • Quilter Plc first reported a position in Ocular Therapeutix in Q4 2019 and held it in 8 quarters.
  • Quilter Plc's Ocular Therapeutix position peaked at $2.02M in Q4 2020.
  • 140 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2021.

Based on Quilter Plc's 13F filing for Q4 2021, filed 14 Feb 2022.